Spinach and lemon extracts for healthy, active aging are the newest additions to a line of Mediterranean plant-based ingredients from Spain-based supplier Euromed. The two new branded ingredients, Spisar and Wellemon, will be showcased at the upcoming SupplySide West trade show in Las Vegas.
Spisar, extracted from Spanish spinach leaves (Spinacia oleracea L.), is standardized to 20-hydroxyecdysone. According to the company, “Spinach’s natural phytohormone ecdysterone is considered both ergogenic and adaptogenic, contributing to the preservation of muscle function. This has proven to be particularly beneficial for those aged 50-plus, in combination with strength training.” In fact, the company says, a 12-week randomized, double-blind, placebo-controlled study that has been submitted for publication found that adults supplementing with Spisar saw benefits in exercise performance and in some variables related to muscle function.
Wellemon, meanwhile, is extracted from Spanish lemon and has a standardized content of the natural flavonoid eriocitrin. Lemons have the highest content of eriocitrin among all citrus species, the company says. Eriocitrin offers antioxidant and healthy-aging benefits. The company says a clinical study1 showed that, due to its high water solubility, eriocitrin is highly bioavailable compared to analogues such as hesperidin found in oranges. The ingredient shows promise for cardiovascular, metabolic, and vascular support.
Euromed offers many other ingredients from the Mediterranean diet that are rich in polyphenols, antioxidants, and other nutrients, including olive, pomegranate, fig, and artichoke extracts. The ingredients are sustainably sourced and processed with a water-only extraction technology called Pure-Hydro Process, which preserves the plant’s natural phytochemicals and avoids undesirable organic solvent residues.
Reference
- Avila-Galvez MA et al. “New insights into the metabolism of the flavanones eriocitrin and hesperidin: A comparative human pharmacokinetic study.” Antioxidants (Basel), vol. 10, no. 3 (March 11, 2021): 435